Even during the COVID-19 pandemic, the fight to end tuberculosis (TB) continues. This year’s virtual Union Conference provides an opportunity to advance efforts to prevent TB and COVID-19 as well as to look at the intersections between them.
Integrating prevention and high-impact treatment practices into national TB programs creates locally sustainable solutions. The global health community is making progress, but gaps still remain. One-third of people living with TB are undiagnosed or go unreported, which is why FHI 360 is committed to developing and implementing evidence-based interventions and innovative tools for finding and treating missing people with TB in both the public and private sector. More than two-thirds of people with TB symptoms in high-burden countries seek care in the private-sector health system but may not be correctly diagnosed or receiving appropriate treatment. Our engagement with the private sector has resulted in lower drug prices and the removal of treatment barriers for people living with multidrug-resistant TB.
Explore our technical presence at this year’s conference and learn more about FHI 360’s work to reduce the burden of this preventable and treatable infectious disease.
